Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.29%75.7B | 5.28%315.42B | 6.07%74.73B | 8.92%299.6B | 6.73%73.9B | 15.12%82.87B | 7.21%72.37B | 6.23%70.45B | 8.55%275.06B | 12.65%69.24B |
| Cost of revenue | 3.77%48.21B | 4.65%199.51B | 4.19%46.46B | 7.61%190.64B | 5.92%47.65B | 15.44%52.13B | 4.03%46.27B | 4.84%44.59B | 11.85%177.16B | 13.85%44.99B |
| Gross profit | -2.78%27.49B | 6.38%115.91B | 9.32%28.28B | 11.29%108.96B | 8.25%26.25B | 14.57%30.74B | 13.33%26.1B | 8.71%25.87B | 3.05%97.9B | 10.50%24.25B |
| Operating expense | 6.04%24.07B | 7.18%95.91B | 8.34%22.7B | 10.18%89.49B | 7.13%23.45B | 9.93%22.14B | 12.66%22.95B | 11.31%20.95B | 7.18%81.22B | 11.64%21.89B |
| Operating profit | -38.71%3.42B | 2.74%20B | 13.52%5.58B | 16.68%19.47B | 18.59%2.8B | 28.54%8.6B | 18.48%3.15B | -1.15%4.91B | -13.22%16.69B | 0.90%2.36B |
| Net non-operating interest income (expenses) | -129.17%-14M | 79.14%335M | 223.08%48M | 938.89%187M | 386.96%112M | 933.33%125M | -320.00%-11M | -880.00%-39M | -89.94%18M | -68.06%23M |
| Non-operating interest income | 35.71%76M | 18.96%433M | -3.45%56M | 15.56%364M | 9.57%126M | 22.78%97M | 18.57%83M | 13.73%58M | 31.25%315M | 17.35%115M |
| Non-operating interest expense | 1,025.00%90M | -44.63%98M | -91.75%8M | -40.40%177M | -84.78%14M | -129.79%-28M | 44.62%94M | 110.87%97M | 386.89%297M | 253.85%92M |
| Net investment income | 72.17%198M | -40.82%519M | -58.63%115M | 0.92%877M | 158.99%562M | 42.07%-157M | -61.81%194M | -33.01%278M | -16.92%869M | -44.92%217M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 96.28%4.12B | -153M | -30.60%2.1B | 286.87%370M | -99.42%15M | 1,796.04%1.71B | 0 | 0.77%3.02B | -132.94%-198M |
| Income from associates and other participating interests | -20.83%-58M | 144.00%183M | 61.90%-48M | -46.04%75M | 14.89%54M | 20.78%93M | -16.92%54M | -152.00%-126M | 143.17%139M | 115.61%47M |
| Special income (charges) | -99.15%3M | -229.68%-5.31B | -94.96%352M | 7,282.46%4.09B | -1,610.63%-2.42B | -4.29%-73M | -326.32%-405M | 13,540.38%6.99B | 94.51%-57M | 125.76%160M |
| Less:Other special charges | 116.76%59M | -162.26%-231M | -4,928.57%-352M | 150.96%371M | 124.51%212M | 17.54%67M | 160.53%99M | -116.67%-7M | -281.09%-728M | -736.03%-865M |
| Less:Write off | ---62M | 224.08%5.54B | --0 | -668.79%-4.47B | 212.77%2.21B | -53.85%6M | 436.84%306M | -69,920.00%-6.98B | 23.43%785M | 45.36%705M |
| Other non-operating income (expenses) | 227.03%121M | -26.68%349M | -83.56%37M | -25.04%476M | -147.50%-57M | 37.40%180M | -3.76%128M | -10.36%225M | -50.27%635M | 14.29%120M |
| Income before tax | -38.16%3.67B | -25.95%20.2B | -51.56%5.93B | 27.97%27.28B | -47.97%1.42B | -3.85%8.79B | 51.92%4.83B | 95.39%12.24B | -8.79%21.32B | 43.57%2.74B |
| Income tax | -19.40%1.51B | -27.31%5.89B | -50.80%1.87B | 38.15%8.11B | -156.91%-70M | 0.95%2.65B | 111.76%1.73B | 64.77%3.8B | -22.03%5.87B | -87.13%123M |
| Net income | -46.81%2.16B | -25.37%14.31B | -51.90%4.06B | 24.09%19.17B | -42.88%1.49B | -5.77%6.14B | 31.17%3.1B | 113.24%8.44B | -2.50%15.45B | 175.24%2.61B |
| Net income continuous operations | -46.81%2.16B | -25.38%14.3B | -51.90%4.06B | 24.10%19.17B | -42.84%1.49B | -5.78%6.14B | 31.23%3.1B | 113.24%8.44B | -2.50%15.45B | 175.24%2.61B |
| Noncontrolling interests | -28.63%359M | 14.11%1.81B | 9.35%503M | -10.54%1.59B | -49.82%274M | 49.63%603M | -46.12%250M | 27.42%460M | -5.94%1.77B | 54.67%546M |
| Net income attributable to the company | -49.35%1.8B | -28.94%12.49B | -55.43%3.56B | 28.58%17.58B | -41.05%1.22B | -9.42%5.54B | 50.16%2.85B | 121.80%7.98B | -2.03%13.67B | 246.64%2.07B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -49.35%1.8B | -28.94%12.49B | -55.43%3.56B | 28.58%17.58B | -41.05%1.22B | -9.42%5.54B | 50.16%2.85B | 121.80%7.98B | -2.03%13.67B | 246.64%2.07B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -47.70%19.2 | -26.96%131.86 | -55.12%36.71 | 29.29%180.53 | -39.78%12.79 | -9.20%56.76 | 50.08%29.19 | 124.51%81.79 | -0.09%139.63 | 248.20%21.24 |
| Diluted earnings per share | -47.70%19.2 | -26.96%131.86 | -55.12%36.71 | 29.29%180.53 | -40.64%12.5723 | -9.20%56.76 | 50.16%29.1885 | 124.51%81.79 | -0.09%139.63 | 253.90%21.1814 |
| Dividend per share | 0 | 2.13%48 | 0 | 2.17%47 | 4.35%24 | 0 | 0.00%23 | 0 | 0.00%46 | 0.00%23 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |